Cargando…
Management of pemphigus
Pemphigus is an autoimmune blistering disease characterized by cutaneous and mucosal blisters and erosions. Though systemic corticosteroids have been the mainstay of treatment for pemphigus over the years, more recently research has focused on steroid-sparing agents. This review looks at the commonl...
Autores principales: | Daniel, Benjamin S., Murrell, Dedee F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017903/ https://www.ncbi.nlm.nih.gov/pubmed/24860654 http://dx.doi.org/10.12703/P6-32 |
Ejemplares similares
-
Validation studies of outcome measures in pemphigus()()()
por: Hanna, Sarah, et al.
Publicado: (2016) -
Bruton Tyrosine Kinase Inhibition and Its Role as an Emerging Treatment in Pemphigus
por: Patsatsi, Aikaterini, et al.
Publicado: (2021) -
Treatment considerations for patients with pemphigus during the COVID-19 pandemic
por: Shakshouk, Hadir, et al.
Publicado: (2020) -
New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature()()
por: Xuan, Rachel R., et al.
Publicado: (2018) -
Considerations for the use of immunosuppression for the management of pemphigus during the COVID-19 pandemic with a focus on rituximab: Case reports from a single center experience in Australia
por: Koszegi, Ben, et al.
Publicado: (2023)